British Society for Rheumatology Guideline on Management of Paediatric, Adolescent and Adult Patients with Idiopathic Inflammatory Myopathy

Gitiaux C, Antonio M, Aouizerate J, Gherardi R, Guilbert T, Barnerias C . Vasculopathy-related clinical and pathological features are associated with severe juvenile dermatomyositis. Rheumatology (Oxford). 2015; 55(3):470-9. DOI: 10.1093/rheumatology/kev359. View

Ladislau L, Suarez-Calvet X, Toquet S, Landon-Cardinal O, Amelin D, Depp M . JAK inhibitor improves type I interferon induced damage: proof of concept in dermatomyositis. Brain. 2018; 141(6):1609-1621. DOI: 10.1093/brain/awy105. View

Keysser G, Zierz S, Kornhuber M . Treatment of adult idiopathic inflammatory myopathies with conventional immunosuppressive drugs : Results of a retrospective study. Z Rheumatol. 2018; 78(2):183-189. DOI: 10.1007/s00393-018-0471-0. View

Barth Z, Schwartz T, Flato B, Aalokken T, Koller A, Lund M . Association Between Nailfold Capillary Density and Pulmonary and Cardiac Involvement in Medium to Longstanding Juvenile Dermatomyositis. Arthritis Care Res (Hoboken). 2018; 71(4):492-497. DOI: 10.1002/acr.23687. View

Paik J, Casciola-Rosen L, Shin J, Albayda J, Tiniakou E, Leung D . Study of Tofacitinib in Refractory Dermatomyositis: An Open-Label Pilot Study of Ten Patients. Arthritis Rheumatol. 2020; 73(5):858-865. PMC: 8084900. DOI: 10.1002/art.41602. View

Tjarnlund A, Tang Q, Wick C, Dastmalchi M, Mann H, Tomasova Studynkova J . Abatacept in the treatment of adult dermatomyositis and polymyositis: a randomised, phase IIb treatment delayed-start trial. Ann Rheum Dis. 2017; 77(1):55-62. DOI: 10.1136/annrheumdis-2017-211751. View

Huber A, Ward L . The impact of underlying disease on fracture risk and bone mineral density in children with rheumatic disorders: A review of current literature. Semin Arthritis Rheum. 2016; 46(1):49-63. DOI: 10.1016/j.semarthrit.2016.02.003. View

Newman E, Scott D . The Use of Low-dose Oral Methotrexate in the Treatment of Polymyositis and Dermatomyositis. J Clin Rheumatol. 2008; 1(2):99-102. DOI: 10.1097/00124743-199504000-00007. View

Tansley S, Simou S, Shaddick G, Betteridge Z, Almeida B, Gunawardena H . Autoantibodies in juvenile-onset myositis: Their diagnostic value and associated clinical phenotype in a large UK cohort. J Autoimmun. 2017; 84:55-64. PMC: 5656106. DOI: 10.1016/j.jaut.2017.06.007. View

10.

Na S, Kim S, Sunwoo I, Choi Y . Clinical characteristics and outcomes of juvenile and adult dermatomyositis. J Korean Med Sci. 2009; 24(4):715-21. PMC: 2719214. DOI: 10.3346/jkms.2009.24.4.715. View

11.

Villalba L, Hicks J, Adams E, Sherman J, Gourley M, Leff R . Treatment of refractory myositis: a randomized crossover study of two new cytotoxic regimens. Arthritis Rheum. 1998; 41(3):392-9. DOI: 10.1002/1529-0131(199803)41:3<392::AID-ART3>3.0.CO;2-X. View

12.

de Groot K, Adu D, Savage C . The value of pulse cyclophosphamide in ANCA-associated vasculitis: meta-analysis and critical review. Nephrol Dial Transplant. 2001; 16(10):2018-27. DOI: 10.1093/ndt/16.10.2018. View

13.

Coyle K, Rother K, Weise M, Ahmed A, Miller F, Rider L . Metabolic abnormalities and cardiovascular risk factors in children with myositis. J Pediatr. 2009; 155(6):882-7. PMC: 2809424. DOI: 10.1016/j.jpeds.2009.06.009. View

14.

Rennebohm R, Jones K, Huber A, Ballinger S, Bowyer S, Feldman B . Normal scores for nine maneuvers of the Childhood Myositis Assessment Scale. Arthritis Rheum. 2004; 51(3):365-70. DOI: 10.1002/art.20397. View

15.

Huber A, Mamyrova G, Lachenbruch P, Lee J, Katz J, Targoff I . Early illness features associated with mortality in the juvenile idiopathic inflammatory myopathies. Arthritis Care Res (Hoboken). 2013; 66(5):732-40. PMC: 4646219. DOI: 10.1002/acr.22212. View

16.

Faller G, Mistry B, Tikly M . Juvenile dermatomyositis in South African children is characterised by frequent dystropic calcification: a cross sectional study. Pediatr Rheumatol Online J. 2014; 12:2. PMC: 3896965. DOI: 10.1186/1546-0096-12-2. View

17.

Vancsa A, Ponyi A, Constantin T, Zeher M, Danko K . Pregnancy outcome in idiopathic inflammatory myopathy. Rheumatol Int. 2006; 27(5):435-9. DOI: 10.1007/s00296-006-0239-8. View

18.

Gupta L, Lawrence A, Edavalath S, Misra R . Prevalence and predictors of asymptomatic vertebral fractures in inflammatory myositis. Int J Rheum Dis. 2018; 21(3):725-731. DOI: 10.1111/1756-185X.13257. View

19.

Diederichsen L, Diederichsen A, Simonsen J, Junker P, Sondergaard K, Lundberg I . Traditional cardiovascular risk factors and coronary artery calcification in adults with polymyositis and dermatomyositis: a Danish multicenter study. Arthritis Care Res (Hoboken). 2014; 67(6):848-54. DOI: 10.1002/acr.22520. View

20.

Parraga Prieto C, Ibrahim F, Campbell R, Chinoy H, Galloway J, Gordon P . Similar risk of cardiovascular events in idiopathic inflammatory myopathy and rheumatoid arthritis in the first 5 years after diagnosis. Clin Rheumatol. 2020; 40(1):231-238. PMC: 7782367. DOI: 10.1007/s10067-020-05237-7. View